Gene Copy Number Detection: Technical Principles, Methods, and Applications

Gene copy number detection is a molecular analysis technique used to determine the exact number of copies of a specific gene, transgene, or DNA sequence within a genome, supporting applications that range from genetically modified organism (GMO) event characterization to genetic disease diagnosis and biopharmaceutical cell line development. Using validated quantitative approaches such as real-time quantitative PCR (qPCR), digital droplet PCR (ddPCR), fluorescence in situ hybridization (FISH), and next-generation sequencing (NGS), accredited third-party laboratories deliver accurate, standards-compliant copy number data for research, breeding, regulatory submission, and clinical decision-making.

Technical Overview

Gene copy number detection refers to the quantitative determination of how many copies of a particular gene, DNA sequence, or integrated transgene are present within a genome. In diploid organisms, most endogenous genes exist in two copies, one on each homologous chromosome. Deviations from this baseline, collectively known as copy number variations (CNVs), include deletions (reduced copy number) and duplications or amplifications (increased copy number). Because gene dosage directly influences mRNA transcript levels, protein expression, phenotype, and trait stability, precise copy number measurement is a fundamental requirement across molecular biology, agricultural biotechnology, genetic breeding, and clinical diagnostics.

In agricultural biotechnology, every transgenic event must be characterized to determine how many copies of the exogenous expression construct have integrated into the host genome. Single-copy insertions are generally preferred because they provide stable Mendelian inheritance, predictable expression levels, simplified breeding programs, and smoother regulatory review. In clinical settings, germline CNVs underlie numerous inherited disorders, such as Duchenne muscular dystrophy, spinal muscular atrophy, and Charcot-Marie-Tooth disease type 1A, while somatic gene amplifications, such as HER2 in breast cancer or EGFR and MET in lung cancer, serve as actionable biomarkers that directly guide therapy selection.

Methodological quality is anchored in internationally recognized standards. ISO 21570 specifies quantitative nucleic acid-based methods for GMO analysis, ISO 21571 addresses nucleic acid extraction, and ISO 24276 defines general requirements and definitions for GMO detection. ISO 20395 provides criteria for evaluating the performance of qPCR methods, including inclusivity, exclusivity, and limits of detection. Reputable testing is typically performed by accredited third-party laboratories operating under an ISO/IEC 17025 quality management system, ensuring traceable, reproducible, and defensible results.

Testing Samples

Plant Samples

Fresh leaves, seeds, seedlings, or flour derived from genetically modified or gene-edited crops such as maize, soybean, cotton, rice, rapeseed, and wheat are commonly submitted. Genomic DNA is extracted using CTAB-based protocols or commercial silica-column kits. Samples should meet basic quality criteria, including an A260/280 absorbance ratio of approximately 1.8 to 2.0, sufficient concentration, and intact high-molecular-weight DNA verified by agarose gel electrophoresis.

Animal Samples

Ear notches, tail tips, blood collected in EDTA anticoagulant, hair follicles, and tissue biopsies from transgenic animals, cloned livestock, or breeding populations are suitable. Heparinized blood should be avoided because heparin is a known PCR inhibitor. Properly labeled, fresh, or frozen tissue can generally be accommodated, and dried sample formats such as FTA cards are also acceptable for many assays.

Human Clinical Samples

Peripheral blood is the standard matrix for germline copy number analysis of disease-associated genes. For somatic oncology applications, fresh frozen tissue, formalin-fixed paraffin-embedded (FFPE) tissue sections, or extracted tumor DNA may be analyzed, with DNA quality scores used to assess FFPE suitability. Clinical testing must follow appropriate ethical approval and informed consent requirements.

Microbial and Cell Line Samples

Bacterial colonies, glycerol stocks, plasmid preparations, and engineered production cell lines such as CHO or HEK293 cells are analyzed to quantify plasmid, vector, or transgene copy number. Serial passages can be tested to monitor genetic stability during master cell bank establishment and biopharmaceutical process development.

Testing Items

Typical gene copy number detection portfolio covers the following core testing items:

• Transgene copy number determination for GM plants and animals, including constructs containing Cry1Ab, Cry1Ac, EPSPS, Bar/PAT, or selectable markers such as HPT and NPTII.
• Endogenous reference gene qualification and validation, confirming species-specific single-copy references such as zSSIIb for maize, Lectin for soybean, Sad1 for cotton, and SPS for rice.
• Zygosity determination to distinguish homozygous lines from hemizygous or heterozygous lines in breeding programs.
• Gene dosage and CNV analysis for disease-associated human genes, including deletions and duplications across targeted loci.
• Oncology gene amplification testing for biomarkers such as HER2 (ERBB2), EGFR, MET, MYC, and CCND1.
• Plasmid, vector, and transgene copy number quantification in microbial strains and mammalian production cell lines.
• Copy number stability monitoring across generations or cell culture passages to demonstrate genetic stability.

Testing Methods

Real-Time Quantitative PCR (qPCR)

qPCR remains the most widely used platform for copy number determination. Relative quantification compares the cycle threshold (Ct) of the target gene against a validated endogenous reference gene using the ΔΔCt calculation, while absolute quantification employs calibrated standard curves. TaqMan hydrolysis probes offer high specificity, whereas SYBR Green chemistry provides a cost-effective alternative when melt-curve confirmation is performed. The method is fast, sensitive, and scalable, but it requires a stable reference gene, rigorous control of amplification efficiency, and validation consistent with ISO 20395.

Digital Droplet PCR (ddPCR)

ddPCR partitions the reaction into thousands of individual nanoliter droplets, each undergoing endpoint PCR. Counting positive and negative droplets and applying Poisson statistics yields absolute copy number quantification without external calibration curves. ddPCR offers superior precision for discriminating adjacent copy number states, such as one versus two versus three copies, and is therefore the preferred method for zygosity confirmation and integration copy analysis. It also demonstrates enhanced tolerance to matrix inhibitors and minor template concentration differences.

Fluorescence In Situ Hybridization (FISH)

FISH uses fluorescently labeled DNA probes that hybridize to metaphase chromosome spreads or interphase nuclei, revealing the physical location and copy number of the target sequence on each chromosome. It is particularly valuable for confirming integration sites, characterizing rearrangements, and validating results obtained by PCR-based methods.

Multiplex Ligation-Dependent Probe Amplification (MLPA)

MLPA enables simultaneous interrogation of dozens of loci in a single reaction through probe ligation and subsequent fluorescent PCR. It is a well-established clinical technique for CNV screening of disorders involving exon-level deletions or duplications, such as Duchenne muscular dystrophy and spinal muscular atrophy.

Next-Generation Sequencing (NGS)

Low-pass whole-genome sequencing provides cost-effective, genome-wide CNV profiling, while targeted deep amplicon or capture sequencing resolves focal amplifications and rearrangements. Whole-genome sequencing additionally identifies unknown insertion patterns and junction sequences, making NGS increasingly important for comprehensive genomic characterization.

Southern Blot Analysis

Southern blotting remains a classical confirmatory technique in which restriction-digested genomic DNA is separated, transferred, and hybridized with labeled probes. It is free from PCR amplification bias and provides direct evidence of insertion copy number and integration pattern, which is why it is frequently requested in regulatory dossiers, despite requiring larger quantities of high-quality DNA.

Method selection depends on the intended use. qPCR suits high-throughput screening, ddPCR delivers the highest precision for copy and zygosity calls, FISH and Southern blot provide orthogonal structural confirmation, and NGS offers genome-wide discovery capability.

Applications

Gene copy number detection supports a broad spectrum of scientific, industrial, and clinical applications:

• GM crop development and regulatory compliance, including transgenic event characterization, insertion copy analysis, and genetic stability demonstration in line with ISO 21570 and ISO 24276 frameworks.
• Molecular breeding and seed quality control, enabling early-generation homozygosity screening and marker-assisted selection to accelerate breeding cycles.
• Transgenic animal line validation for pharmaceutical models, disease models, and improved livestock breeds.
• Clinical genetics diagnostics, detecting pathogenic deletions and duplications in inherited neuromuscular, neurodevelopmental, and metabolic disorders.
• Precision oncology, quantifying gene amplification biomarkers that inform targeted therapy and prognosis decisions.
• Biopharmaceutical cell line development, monitoring vector copy number and expression cassette stability during clone selection and cell bank qualification.
• Academic and gene therapy research, including vector genome quantification and construct integrity assessment.

FAQ

What is the difference between qPCR and ddPCR for copy number detection?

qPCR relies on relative or standard-curve-based quantification and is well suited for rapid, high-throughput screening. ddPCR performs absolute quantification through droplet partitioning and Poisson statistics, delivering better precision at low copy numbers and more reliable discrimination between adjacent copy number states, such as distinguishing one copy from two. For critical zygosity calls or regulatory submissions, ddPCR is often recommended, sometimes with qPCR as the initial screen.

How much sample and DNA are required?

Typical requirements are 50 to 200 ng of purified genomic DNA per reaction for qPCR or ddPCR, meaning a fresh leaf disc, an ear notch, or 100 to 200 μL of EDTA blood is usually sufficient. DNA should be free of inhibitors, with an A260/280 ratio near 1.8 to 2.0 and verified integrity. Southern blot and NGS workflows require microgram quantities of high-molecular-weight DNA.

Can copy number testing distinguish homozygous from heterozygous individuals?

Yes. ddPCR measures the ratio of the target gene to a known single-copy endogenous reference gene. A ratio of approximately 1.0 indicates one inserted copy in a hemizygous or heterozygous state, while a ratio of approximately 2.0 indicates two copies consistent with homozygosity, assuming a diploid genome and single-locus integration. FISH provides complementary confirmation by visualizing signal distribution across homologous chromosomes.

Which standards and quality systems apply?

GMO-related copy number analysis references ISO 21570, ISO 21571, and ISO 24276, while qPCR method performance is evaluated according to ISO 20395. National standards such as the GB/T 19495 series may also apply for certain markets. Reliable testing is conducted by accredited third-party laboratories operating under ISO/IEC 17025, with documented method validation covering linearity, repeatability, limits of detection and quantification, and regular participation in proficiency testing schemes.

What is the typical turnaround time?

Standard qPCR or ddPCR copy number testing generally requires five to ten working days after satisfactory DNA extraction and quality checks. Projects involving method development for novel constructs, Southern blot confirmation, or NGS-based characterization typically require two to four weeks, depending on sample quantity and project complexity.

How is result accuracy ensured?

Accredited laboratories incorporate positive and negative controls, no-template controls, replicate reactions, and calibrated reference materials in every run. Validation parameters, including amplification efficiency, precision, and copy number resolution, are documented according to ISO 20395 and ISO/IEC 17025 requirements. Orthogonal confirmation, such as ddPCR cross-checking qPCR results or FISH confirming integration patterns, further strengthens the reliability of reported copy number calls.